Further testing service agreement with MyHealthChecked plc

Manchester, UK – 17 May 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that its partner MyHealthChecked plc (AIM:MHC) (“MyHealthChecked”) has signed a second COVID-19 testing services agreement, to support the supply of the MyHealthChecked™ COVID-19 at-home nasal swab kit, PCR laboratory testing service and logistics for day two and day eight (“D2/D8”) coronavirus testing for international arrivals, to Boots UK Limited (“Boots”), the health and beauty retailer and pharmacy group.

Through the service agreement, a proportion of the MyHealthChecked™ COVID-19 tests will be processed by Yourgene Genomic Services (“YGS”) at the Company’s Citylabs 1.0 laboratory in Manchester which are well equipped to deal with the anticipated increased demand for D2/D8 testing. In addition, samples processed at MyHealthChecked's own laboratories will use Yourgene's Clarigene® SARS CoV-2 PCR CE-IVD test kit. MyHealthChecked is currently the only at-home testing kit provider within Boots for General Testing and Fit-to-Fly services, as launched on 7 April 2021, and is now accompanied by D2/D8 tests that will be available to purchase online, via www.boots.com across the UK, from 17 May 2021.

Lyn Rees, CEO of Yourgene Health and Non-Executive Director of MyHealthChecked, commented: “This further contract with Boots is another significant milestone for MyHealthChecked and Yourgene is pleased to continue supporting their COVID-19 testing service and product supply to their laboratory. With the introduction of the new traffic light system in the UK for global travel, we will see an increased demand for D2/D8 testing, as travel resumes, and this further contract for MyHealthChecked is a testament to the quality of the service provided.”